Scalable iPSC-Derived Hematopoietic Stem & Progenitor Cell (HSPC) Manufacturing in Vertical-Wheel Bioreactors for Clinical Cell Therapy Production
Time: 3:30 pm
day: Day 1 PM
Details:
- Define critical process parameters to maximize yield and quality of HSPC production using Vertical-Wheel bioreactors
- Develop scalable HSPC manufacturing with high lymphoid potential for downstream differentiation to iNK, gd-iT, and ab-iT effector cell types
- IPSC-derived T cell expansion in vertical-wheel bioreactors provides a path for clinical g/d iT manufacturing
